Are you a medical professional?
No
Yes
About vaccine
Convacell
Clinical trials
Scientific publications
Recombinant technology
Contacts
Q&A
ru
es
ru
es
About vaccine
About vaccine
Convacell
Clinical trials
Scientific publications
Recombinant technology
Contacts
Q&A
Home
About vaccine
Scientific publications about the vaccine
15.03.2023
Immunogenicity and in vivo protective effects of recombinant nucleocapsid-based SARS-CoV-2 vaccine Convacell®
30.09.2022
SARS-CoV-2 N-protein vaccine generates pronounced T-cell immunity to the N protein of new strains
Scientific publications about N protein
28.04.2023
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
28.04.2023
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
06.09.2022
Nucleocapsid as a next-generation COVID-19 vaccine candidate
05.07.2022
Next generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection
03.07.2022
Nucleocapsid as a next-generation COVID-19 vaccine candidate
04.06.2022
Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity
09.05.2022
Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine
24.09.2021
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
